Although Lenalidomide strongly enhanced the reduction of CK1α, no alterations of FOXO3a phosphorylation were observed (not shown), suggesting that in MM FOXO3a phosphorylation could not depend on CK1α. The gene discussed is CSNK1A1; the disease is Miyoshi myopathy.